Sunday, 29 March 2020

Japan News

  • Japan to develop vaccine for H7N9 bird flu

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2013

    Singapore: A panel of experts at the Health, Labor and Welfare Ministry of Japan will start producing a vaccine for the H7N9 strain of avian influenza, according to a report published by Th...Read more

  • Kitasato Daiichi Sankyo to shut animal vaccine unit

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 21 Sep, 2012

    Singapore: Daiichi Sankyo's animal vaccine unit, Kitasato Daiichi Sankyo Vaccine is discontinuing its animal vaccine business at the end of FY2013 in order to focus resources on vaccines fo...Read more

  • OptiMedica expands footprint in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 15 Aug, 2012

    Singapore: Global ophthalmic company OptiMedica has expanded international market adoption of its Catalys Precision Laser System with new installations at the premier Shinagawa LASIK Cente...Read more

  • WaferGen, Qiagen sign Next-Gen sequencing deal

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 20 Feb, 2013

    Singapore: WaferGen Bio-systems announced a co-marketing agreement with Qiagen for the promotion of certain products in Japan in the areas of genomics platforms such as Next-Gen sequencing ...Read more

  • Novartis's Ultibro Breezhaler receives EC, Japanese nod

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Sep, 2013

    Singapore: Novartis has announced that the European Commission has approved once-daily Ultibro Breezhaler (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatm...Read more

  • Shimadzu India aims at 15-20% growth

    Japan |  Influencers | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

    With a view of expanding their customer base, Shimadzu Analytical India has been taking concrete steps towards connecting with their customers through various initiatives. Recently, it orga...Read more

  • Ex-GSK boss promoted as Takeda's CEO

    Japan |  Influencers | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Japan's Takeda Pharmaceutical has promoted Mr Christophe Weber, representative director, president and chief operating Officer (COO), as the chief executive officer (CEO) of the ...Read more

  • Millennium starts ph III trial for multiple myeloma drug

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2012

    Singapore: Millennium: The Takeda Oncology Company, has initiated an international phase III clinical trial evaluating MLN9708 in patients with relapsed or refractory multiple myeloma. The ...Read more

  • Astellas looks to sell dermatology assets: Sources

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2013

    Singapore: Japan-based drugmaker Astellas Pharma is planning to sell its dermatology portfolio, which could be worth between $500 million and $1 billion, according to the sources. Astellas...Read more

  • SymBio Pharma completes patient enrollment

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Mar, 2013

    Singapore: Japan-headquartered SymBio Pharmaceuticals has completed patient enrollment for its phase II clinical trial of Treakisym (bendamustine hydrochloride, SyB L-0501) in frontline low...Read more

  • OMRON reports performance for Q1 2012

    Japan |  Company results | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2012

    Singapore: OMRON Corporation reported consolidated performance for the first quarter (Q1) of fiscal 2012, which included the three months from April 1-to-June 30, 2012. Omron group's net sa...Read more

  • International consortium sequences tomato genome

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

    Singapore: The Tomato Genome Consortium (TGC), which is a group of over 300 scientists from 13 countries sequenced the genomes of the domesticated tomato and its wild ancestor, Solanum pimp...Read more

  • Japan approves world's first transdermal ß1-blocker patch

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2013

    Singapore: Japan-based Nitto Denko announced that Toa Eiyo has received manufacturing and marketing authorization in Japan from the Japanese Ministry of Health, Labour and Welfare for "Biso...Read more

  • Eisai, Toyama get marketing approval for iguratimod

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2012

    Singapore: Eisai and Toyama Chemical have received approval from Japan's Ministry of Health, Labour and Welfare to market iguratimod for the treatment of rheumatoid arthritis. Iguratimod, ...Read more

  • Daiichi to launch Inavir anti-influenza product in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 16 Nov, 2012

    Singapore: Daiichi Sankyo submitted an application for a partial label change in Japan to manufacture and market the influenza anti-viral product Inavir Dry Powder Inhaler (laninamivir octa...Read more

  • FDA slams Shionogi for eyeing profit over patient safety

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 30 May, 2013

    Singapore: The FDA had during September 2012 informed Shionogi that it need to conduct two clinical trials in order to evaluate the risk of irregular heartbeat associated with its Rybix pai...Read more

  • Medical laser market to reach $8.8 bn by 2018: GIA

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Jul, 2013

    Singapore: Technological advancements in laser technology have created a plethora of applications in the medical field, leading to significant rise in the number of procedures carried out u...Read more

  • Chugai, Nippon Shinyaku tie up for drug development

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

    Singapore: Tokyo-headquartered Chugai Pharmaceutical and Kyotobased Nippon Shinyaku have entered into an agreement to co-develop and co-market GA101 (obinutuzumab), the first glycoengineere...Read more



Podcast

 

Survey Box

Are women in the industry getting the required recognition for their efforts?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls